[1] |
Chen Hongjian, Zhang Suqing.
Study on the relationship between serum miR-24-3p, H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients
[J]. Journal of International Oncology, 2024, 51(6): 344-349.
|
[2] |
Peng Qin, Cai Yuting, Wang Wei.
Advances on KPNA2 in liver cancer
[J]. Journal of International Oncology, 2024, 51(3): 181-185.
|
[3] |
Gong Yan, Chen Honglei.
Research progress on the mechanism of microRNA regulation of cisplatin resistance in ovarian cancer
[J]. Journal of International Oncology, 2024, 51(3): 186-190.
|
[4] |
Sun Guobao, Yang Qian, Zhuang Qingchun, Gao Binbin, Sun Xiaogang, Song Wei, Sha Dan.
Research progress on the histopathological growth patterns of colorectal liver metastasis
[J]. Journal of International Oncology, 2024, 51(2): 114-118.
|
[5] |
Xiang Yuling, Tan Jiajie, Xiong Yuanguo, Zhao Lirong, Li Chen, Zhang Hong.
Effects of Anhydroicaritin on the proliferation, migration and apoptosis of hepatocellular carcinoma cells
[J]. Journal of International Oncology, 2023, 50(9): 513-519.
|
[6] |
Quan Zhenhao, Xu Feipeng, Huang Zhe, Huang Xianjin, Chen Rihong, Sun Kaiyu, Hu Xu, Lin Lin.
lncRNA FTX silencing inhibits gastric cancer cell proliferation through the miR-22-3p/NLRP3 inflammasome pathway
[J]. Journal of International Oncology, 2023, 50(4): 202-207.
|
[7] |
Li Jiaxuan, Feng Yinglu.
Mechanism of action of glucocorticoid receptors in the growth of hepatoma cells
[J]. Journal of International Oncology, 2023, 50(4): 241-243.
|
[8] |
He Ting, Wang Xi, Zhang Huizhong, Liu Xinyang, Wang Huiping, Dong Ke.
Diagnostic value of serum TIM-3 in patients with liver cancer
[J]. Journal of International Oncology, 2022, 49(9): 537-542.
|
[9] |
Zhou Renbang, Zhang Zhongchuan, Xu Zhiyuan, Zhu Xunbing.
MiR-219a-5p inhibits the proliferation, invasion and migration of osteosarcoma U2OS cells by negatively regulating HMGA2
[J]. Journal of International Oncology, 2022, 49(4): 193-198.
|
[10] |
Jin Jiahui, Chen Cunhai, Ma Xuezhen.
Effects of radiation-associated miRNA in radiotherapy for breast cancer
[J]. Journal of International Oncology, 2022, 49(12): 735-738.
|
[11] |
Jing Wenjun, Zhao Wenwen, Feng Qingqing, Zhao Wenfei, Zhao Lili, Zhang Xue, Wei Hongmei.
Molecular basis and clinical prospect of the miR-34 family for the treatment of gastric cancer
[J]. Journal of International Oncology, 2022, 49(11): 681-686.
|
[12] |
Zhang Yumin, Zhao Xianwei, He Qianjin, Chen Jieneng.
Value of contrast-enhanced ultrasound combined with serum CXCL8 and CXCR2 in the evaluation of postoperative efficacy of transcatheter arterial chemoembolization for primary liver cancer
[J]. Journal of International Oncology, 2022, 49(10): 592-596.
|
[13] |
Di Weihua, Zhao Xuemei.
Research progress on the relationship between DNA damage repair genes and liver cancer
[J]. Journal of International Oncology, 2022, 49(10): 635-638.
|
[14] |
Luo Liyun, Lai Canhui, Liang Renpei, Yang Aiwu, Lin Zhimin.
Correlation between the expressions of miR-524-5p and SOX9 in advanced gastric cancer and their influences on chemotherapy efficacy and prognosis
[J]. Journal of International Oncology, 2022, 49(1): 45-50.
|
[15] |
Hong Anlan, Cao Meng, Wang Yan, Fang Fang.
Research progress on lncRNAs as members of ceRNA network in melanoma
[J]. Journal of International Oncology, 2022, 49(1): 61-64.
|